Navin Fluorine International Ltd. announces a new order win
TL;DR
What is the total capital expenditure incurred for this 15K MTPA R32 capacity, and based on previous management guidance, what is the expected asset turnover ratio or peak revenue contribution from this specific facility?
The project capex for the 15K MTPA R32-equivalent facility is ₹236.5 Cr. This is the Board-approved investment amount; the filing does not establish that ₹236.5 Cr was already fully incurred as cash spend. [1]
Implied asset turnover and revenue contribution
Previous management guidance indicated peak annual revenue of ₹600–825 Cr once the facility is fully ramped up. [2]
Using the approved project cost:
- Low case asset turnover: ₹600 Cr / ₹236.5 Cr = 2.54x
- High case asset turnover: ₹825 Cr / ₹236.5 Cr = 3.49x
- Midpoint case: ₹712.5 Cr / ₹236.5 Cr = approximately 3.01x
Thus, the appropriate expectation is roughly 2.5–3.5x asset turnover, or about 3.0x at the midpoint, with a peak revenue contribution of ₹600–825 Cr annually. These are derived peak-state economics, not current revenue: the company stated that the facility would be ramped up progressively after commercial operations began. [1]
The implied range is consistent with the earlier approximate 3x turnover framing, but the more specific management guidance for this R32 facility is the ₹600–825 Cr peak-revenue range. [3]
What is the projected timeline for achieving optimal capacity utilization at the new Surat HFC facility, and how does this ramp-up schedule align with the company's previously disclosed guidance on segment-wise revenue growth for the current fiscal year?
The new Surat HFC capacity is targeted for commissioning in Q3 FY27, but the cited disclosures do not specify when optimal or steady-state utilization will be achieved. The project involves up to 15,000 MTPA of additional R32-equivalent capacity, with estimated peak annual revenue potential of ₹600–825 Cr on completion [3]. A separate report also places commissioning in Q3 FY27 and gives the same peak-revenue range [4].
Alignment with FY27 segment guidance
The timing implies a back-ended revenue contribution:
- Current fiscal year: commissioning is targeted for Q3 FY27, so the facility should contribute only during the latter part of FY27, with the scale of contribution dependent on the pace of qualification, customer ramp-up and utilization.
- Peak revenue: the ₹600–825 Cr potential is a completion-state figure, not FY27 guidance or an implied first-year revenue number [2].
- Segment-wise growth guidance: the cited material does not reproduce the company’s previously disclosed FY27 segment-wise revenue-growth targets. Therefore, the ramp-up cannot be tested precisely against those benchmarks.
Analyst read: the project is more supportive of FY28 and beyond HFC growth than of the full-year FY27 revenue outcome. If management’s FY27 guidance assumed meaningful HFC growth, delivery would likely depend primarily on the existing HFC business and other operating segments, with Surat providing only a partial late-year contribution. The exact “optimal utilization” milestone and its quantitative contribution to FY27 segment revenue could not be confirmed from the cited disclosures.
With the commissioning of this 15K MTPA capacity, how does Navin Fluorine’s total HFC production capacity now compare to key domestic competitors like SRF, and what is the confirmed strategy for the product mix between domestic supply and export markets for this specific R32 output?
Navin Fluorine’s post-commissioning total HFC capacity cannot be quantified from the cited disclosures, and it cannot be numerically ranked against SRF on the evidence available. The commissioned asset is additional capacity of up to 15,000 MTPA of R32-equivalent HFC, not Navin’s total HFC footprint; the Surat plant commenced commercial operations on 12 November 2026 and will be ramped up progressively. [1]
Capacity comparison
- Navin Fluorine: Post-commissioning capacity = previous HFC capacity + up to 15,000 MTPA R32-equivalent. The previous base capacity is not stated in the cited announcement, so reporting 15,000 MTPA as Navin’s total would be incorrect. [1]
- SRF: SRF’s comparable HFC or R32 production capacity for FY26–FY27 could not be confirmed from the cited materials. Accordingly, no defensible numerical comparison with SRF can be made.
The correct conclusion is therefore capacity expansion and improved scale for Navin, but not a verified statement that Navin has overtaken or remains below SRF. The 15K MTPA project has a reported capital cost of ₹236.5 Cr and is being ramped progressively, so its near-term output will also be below full nameplate capacity. [1]
Domestic versus export mix
No confirmed domestic/export allocation or volume split has been disclosed for this specific R32 output in the cited materials. The official disclosure confirms only that the facility is intended to manufacture and supply HFC (R32); it does not identify how much will be sold domestically versus exported. [1]
The available management commentary describes global R32 demand and supply as being in tight balance, but that is market context—not a confirmed allocation strategy for Navin’s new output. [2] Therefore, the project should currently be viewed as market-flexible capacity, rather than explicitly domestic-led or export-led; the exact product-market mix remains unconfirmed.
Sources
- [1]Navin Fluorine Commences Commercial Operations for 15K MTPA R32 Equivalent HFC Capacity at Surat — 2026-11-12T19:16:41.707000, p.1
- [2]Navin Fluorine International (BOM:532504) Q2 2026 Earnings Call Transcript & Audio — Stockanalysis, 2026-11-12T16:09:59.062957
- [3]September 07, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra — Nfil, 2026-09-07T00:00:00
- [4]Navin Fluorine International — Hdfcsec, 2026-08-31T00:00:00
Keep digging